The correlation between systemic inflammatory markers and efficiency for advanced gastric cancer patients treated with ICIs combined with chemotherapy
Immunology · 2024-05 · 172 (1) · 77-90
DOI: 10.1111/imm.13759 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology, online erschienen am 25.01.2024. Verfasst von Qiuxia Dong und 15 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for High Altitude Medicine, Qinghai University, Xining, People's Republic of China. Hauptthemen laut MEDLINE: Stomach Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Science and Technology Department of Qinghai Province.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Currently lacking research to explore the correlation between inflammatory markers and the efficacy of immune checkpoint inhibitors (ICIs) combined with chemotherapy in the treatment of advanced gastric cancer. This study is a retrospective study and included patients with advanced gastric cancer who receiving ICIs combined with chemotherapy from January 2020 to December 2022. We analysed the relationship between systemic inflammatory markers and the efficacy of ICIs combined chemotherapy and constructed a clinical prediction model. A nomogram was constructed based on the results of the bidirectional stepwise regression model. A total of 197 patients were enrolled in the training group, with a median follow‐up period of time 26 months. Kaplan Meier analysis showed that the median OS of patients with low systemic immune‐inflammatory index (SII) and low platelet to lymphocyte ratio (PLR) was superior to those with high SII and PLR. Univariate and multivariate Cox regression analysis showed that SII, NLR, PLR, and N stage as independent prognostic factors for OS. Adding SII to the conventional model improved the predictive ability of the 12‐month OS. A total of 95 patients were included in the validation group, and external validation of the SII‐based nomogram showed favourable predictive performance. Baseline SII, PLR, and N stage may serve as independent predictive factors for survival outcomes in advanced gastric cancer patients undergoing ICIs combined with chemotherapy. The SII‐based nomogram can provide intuitive and accurate prognosis prediction of individual patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Center for High Altitude Medicine, Qinghai University, Xining, People's Republic of China.
- Key Laboratory of Plateau Medicine, Ministry of Education, Qinghai University, Xining, People's Republic of China.
- Qinghai Key Laboratory of Plateau Medical Application Foundation (Qinghai-Utah Joint Research key Laboratory for High Altitude Medicine), Qinghai University, Xining, People's Republic of China.
- Qinghai Red Cross Hospital, The Second Ward of Oncology, Xining, People's Republic of China.
- Breast Disease Diagnosis and Treatment Center, Affiliated Hospital of Qinghai University, Affiliated Cancer Hospital of Qinghai University, Qinghai Provincial Clinical Research Center for Cancer, Qinghai Provincial Inst…
- Affiliated Hospital of Qinghai University, Affiliated Cancer Hospital of Qinghai University, The Second Ward of Oncology, Xining, People's Republic of China.
ORCID-Profile: Jiuda Zhao
Förderung
- Science and Technology Department of Qinghai Province
Zitieren
APA
Dong, Q., Zhao, F., Li, Y., Song, F., Li, E., Gao, L., Xin, Y., Shen, G., Ren, D., Wang, M., Zhao, Y., Liu, Z., Xie, Q., Liu, Z., Li, Z., & Zhao, J. (2024). The correlation between systemic inflammatory markers and efficiency for advanced gastric cancer patients treated with ICIs combined with chemotherapy. Immunology, 172(1), 77-90. https://doi.org/10.1111/imm.13759
Vancouver
Dong Q, Zhao F, Li Y, Song F, Li E, Gao L, et al. The correlation between systemic inflammatory markers and efficiency for advanced gastric cancer patients treated with ICIs combined with chemotherapy. Immunology. 2024;172(1):77-90. doi:10.1111/imm.13759
BibTeX
@article{Dong2024,
author = {Dong, Qiuxia and Zhao, Fuxing and Li, Yuying and Song, Feixue and Li, Enxi and Gao, Lihong and Xin, Yuanfang and Shen, Guoshuang and Ren, Dengfeng and Wang, Miaozhou and Zhao, Yi and Liu, Zhen and Xie, Qiqi and Liu, Zhilin and Li, Zitao and Zhao, Jiuda},
title = {The correlation between systemic inflammatory markers and efficiency for advanced gastric cancer patients treated with ICIs combined with chemotherapy},
journal = {Immunology},
year = {2024},
volume = {172},
number = {1},
pages = {77--90},
doi = {10.1111/imm.13759}
}
EUVIMED